On November 6th, the first Belt and Road conference on scientific and technology exchange in China was held in Chongqing. Professor Qian Cheng, the chairman and chief scientist of Precision Biotech, was invited and gave a keynote speech at the high-end talk of the Future Medical Innovation Cooperation Forum to talk about future medical innovation and cooperation with experts and scholars in the biomedical field at home and abroad.

The first Belt and Road conference on scientific and technology exchange was co-hosted by the Ministry of Science and Technology, the Chinese Academy of Sciences, the Chinese Academy of Engineering, the China Association for Science and Technology, the Chongqing Municipal People's Government and the Sichuan Provincial People's Government, and supported by the National Development and Reform Commission. At the opening ceremony, General Secretary Xi sent a congratulatory letter to gather strong momentum for promoting international scientific and technological cooperation.

Professor Qian Cheng said in his keynote speech that we will always adhere to the mission of "innovation for health", integrate modern AI and biosynthesis technology, and ultimately promote the transformation and application of new drugs. Scientific and technological innovation requires an international perspective to better explore the development path of cutting-edge technologies.

Chongqing Precision Biotech has always adhered to the development strategy of "globalization of scientific research resources and internationalization of technological achievements". While laying out biomedical research and development transformation bases in China, it also actively promotes the globalization strategy of transformation and application of achievements, such as setting up overseas R&D branches and scientific research bases, launching CAR-T new drug registration clinical trials in Europe and the United States, and signing technical licensing and other cooperation agreements with relevant institutions and companies in Brazil, Russia and other countries, benefiting the people's livelihood and well-being of the countries jointly built by the "Belt and Road".

On the same day, the 2023 Sichuan and Chongqing Biomedicine Frontier List was officially released at the conference. Chongqing Precision Biotech's "Key Technology for Intelligent Cell Drug Development" project was also included in the list, which is expected to promote the innovative application of cutting-edge key technologies.